Pomegranate Juice (PJ) And/Or
Pomegranate Extracts (PE) Significantly Inhibit The Growth Of Prostate Cancer
Cells
Pomegranate fruit from the tree Punica granatum has been used for
centuries for medicinal purposes and is described as “nature’s power fruit”.
Recent research has shown that pomegranate juice (PJ) and/or pomegranate
extracts (PE) significantly inhibit the growth of prostate cancer cells (PCa)
in culture. In preclinical murine models, PJ and/or PE inhibit growth and
angiogenesis of prostate tumors.
In a review, published in Int J Mol Sci, the authors have summarized data on the effects of PJ and PE on
prostate cancer. They have also discussed
the effects of specific components of the pomegranate fruit and how they have
been used to study the mechanisms involved in prostate cancer progression and
their potential to be used in deterring prostate cancer metastasis [1].
The pomegranate fruit can be
divided into three major anatomical components: the juice, the pericarp and the
seeds. These discrete components of the pomegranate fruit have been found to
exert anti-proliferative and anti-invasive effects on PCa cells [2]. The juice
and pericarp contain a rich complement of two types of polyphenolic components
which have attracted interest for recent research: anthocyanins which give the
juice its red color [3], such as delphinidin, cyanidin and pelargonidin, and
hydrolyzable tannins, such as the punicalagin and gallagic acid. Other
polyphenolic components of possible interest include kaempferol, quercetin and
luteolin [4].
Anthocyanidins
Recently, it is reported that the three components of PJ, luteolin, ellagic acid and punicic acid together, have similar inhibitory effects on prostate cancer growth, angiogenesis and metastasis [5]. Results from clinical trials are also promising. PJ and/or PE significantly prolonged the prostate specific antigen (PSA) doubling time in patients with prostate cancer [6].
A preventive therapy is far better than a curative one.
Anthocyanidins
Anthocyanidin
|
R3'
|
R4'
|
R5'
|
R3
|
R5
|
R6
|
R7
|
Aurantinidin
|
H
|
OH
|
H
|
OH
|
OH
|
OH
|
OH
|
Cyanidin
|
OH
|
OH
|
H
|
OH
|
OH
|
H
|
OH
|
Delphinidin
|
OH
|
OH
|
OH
|
OH
|
OH
|
H
|
OH
|
Europinidin
|
OCH3
|
OH
|
OH
|
OH
|
OCH3
|
H
|
OH
|
Pelargonidin
|
H
|
OH
|
H
|
OH
|
OH
|
H
|
OH
|
Malvidin
|
OCH3
|
OH
|
OCH3
|
OH
|
OH
|
H
|
OH
|
Peonidin
|
OCH3
|
OH
|
H
|
OH
|
OH
|
H
|
OH
|
Petunidin
|
OH
|
OH
|
OCH3
|
OH
|
OH
|
H
|
OH
|
Rosinidin
|
OCH3 |
OH
|
H
|
OH
|
OH
|
H
|
OCH3
|
Recently, it is reported that the three components of PJ, luteolin, ellagic acid and punicic acid together, have similar inhibitory effects on prostate cancer growth, angiogenesis and metastasis [5]. Results from clinical trials are also promising. PJ and/or PE significantly prolonged the prostate specific antigen (PSA) doubling time in patients with prostate cancer [6].
Important constituents of pomegranate
A preventive therapy is far better than a curative one.
References:
1. Green,
M.-M.; et. al. Pomegranate and Its Components as Alternative Treatment for
Prostate Cancer. Int J Mol Sci. 2014, 15(9), 14949-14966.
2. Lansky, E. P.; et. al. Possible synergistic prostate cancer suppression by anatomically
discrete pomegranate fractions. Investig New Drugs 2005, 23, 11-20.
3. Hernandez, F.; et. al. Evolution of juice anthocyanins
during ripening of new selected pomegranate (punica granatum) clones. Eur Food
Res Technol 1999, 210, 39-42.
4. Gomez-Caravaca
A.M.; et. al. Determination of the major phenolic compounds in pomegranate juices
by HPLC–DAD–ESI-MS. J Agric Food Chem 2013, 61, 5328-5337.
5. Adhami
V. M.; et. al. Cancer chemoprevention by pomegranate: Laboratory and
clinical evidence. Nutr Cancer 2009, 61, 811-815.
6. Paller
C. J.; et. al. A randomized phase
II study of pomegranate extract for men with rising psa following initial
therapy for localized prostate cancer. Prostate Cancer Prostatic Dis 2013, 16, 50-55.